642 related articles for article (PubMed ID: 33838745)
21. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
22. Enhancing tumor T cell infiltration to enable cancer immunotherapy.
Zhang J; Endres S; Kobold S
Immunotherapy; 2019 Feb; 11(3):201-213. PubMed ID: 30730277
[TBL] [Abstract][Full Text] [Related]
23. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities.
Wang Y; Ren S; Wang Z; Wang Z; Zhu N; Cai D; Ye Z; Ruan J
Int Immunopharmacol; 2020 Oct; 87():106815. PubMed ID: 32711376
[TBL] [Abstract][Full Text] [Related]
24. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.
Mishra P; Banerjee D; Ben-Baruch A
J Leukoc Biol; 2011 Jan; 89(1):31-9. PubMed ID: 20628066
[TBL] [Abstract][Full Text] [Related]
25. Chemokines in Leishmaniasis: Map of cell movements highlights the landscape of infection and pathogenesis.
de Araújo FF; Costa-Silva MF; Pereira AAS; Rêgo FD; Pereira VHS; de Souza JP; Fernandes LOB; Martins-Filho OA; Gontijo CMF; Peruhype-Magalhães V; Teixeira-Carvalho A
Cytokine; 2021 Nov; 147():155339. PubMed ID: 33303311
[TBL] [Abstract][Full Text] [Related]
26. CC chemokine receptor 5: the interface of host immunity and cancer.
de Oliveira CE; Oda JM; Losi Guembarovski R; de Oliveira KB; Ariza CB; Neto JS; Banin Hirata BK; Watanabe MA
Dis Markers; 2014; 2014():126954. PubMed ID: 24591756
[TBL] [Abstract][Full Text] [Related]
27. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
28. Multifaceted role of chemokines in solid tumors: From biology to therapy.
Raza S; Rajak S; Tewari A; Gupta P; Chattopadhyay N; Sinha RA; Chakravarti B
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1105-1121. PubMed ID: 34979274
[TBL] [Abstract][Full Text] [Related]
29. Physiology of chemokines in the cancer microenvironment.
Drouillard D; Craig BT; Dwinell MB
Am J Physiol Cell Physiol; 2023 Jan; 324(1):C167-C182. PubMed ID: 36317799
[TBL] [Abstract][Full Text] [Related]
30. Role of Chemokines and Inflammatory Cells in Respiratory Allergy.
Bao Y; Zhu X
J Asthma Allergy; 2022; 15():1805-1822. PubMed ID: 36575714
[TBL] [Abstract][Full Text] [Related]
31. The functional roles of chemokines and chemokine receptors in colorectal cancer progression.
Yue M; Chen MM; Zhang B; Wang Y; Li P; Zhao Y
Biomed Pharmacother; 2024 Jan; 170():116040. PubMed ID: 38113624
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
Yano H; Andrews LP; Workman CJ; Vignali DAA
Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
[TBL] [Abstract][Full Text] [Related]
33. Improving homing in T cell therapy.
Vignali D; Kallikourdis M
Cytokine Growth Factor Rev; 2017 Aug; 36():107-116. PubMed ID: 28690108
[TBL] [Abstract][Full Text] [Related]
34. Chemokines: can effector cells be redirected to the site of the tumor?
Dubinett SM; Lee JM; Sharma S; Mulé JJ
Cancer J; 2010; 16(4):325-35. PubMed ID: 20693843
[TBL] [Abstract][Full Text] [Related]
35. Chemokines: key players in cancer progression and metastasis.
Singh R; Lillard JW; Singh S
Front Biosci (Schol Ed); 2011 Jun; 3(4):1569-82. PubMed ID: 21622291
[TBL] [Abstract][Full Text] [Related]
36. Chemokines and the microenvironment in neuroectodermal tumor-host interaction.
Somasundaram R; Herlyn D
Semin Cancer Biol; 2009 Apr; 19(2):92-6. PubMed ID: 19049876
[TBL] [Abstract][Full Text] [Related]
37. The role of chemokines in the recruitment of lymphocytes to the liver.
Oo YH; Shetty S; Adams DH
Dig Dis; 2010; 28(1):31-44. PubMed ID: 20460888
[TBL] [Abstract][Full Text] [Related]
38. Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.
Pachynski RK; Wang P; Salazar N; Zheng Y; Nease L; Rosalez J; Leong WI; Virdi G; Rennier K; Shin WJ; Nguyen V; Butcher EC; Zabel BA
Front Immunol; 2019; 10():983. PubMed ID: 31139180
[TBL] [Abstract][Full Text] [Related]
39. The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment.
Cardoso AP; Pinto ML; Castro F; Costa ÂM; Marques-Magalhães Â; Canha-Borges A; Cruz T; Velho S; Oliveira MJ
Cytokine Growth Factor Rev; 2021 Aug; 60():107-119. PubMed ID: 33863622
[TBL] [Abstract][Full Text] [Related]
40. Chemokine-chemokine receptors in cancer immunotherapy.
Stewart TJ; Smyth MJ
Immunotherapy; 2009 Jan; 1(1):109-27. PubMed ID: 20635978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
